ACE2 and COVID-19: The receptor-binding domain (RBD) in the spike protein of SARS-CoV-2 is essential to bind with ACE2, and an RBD-Fc-based COVID-19 vaccine protected human ACE2 transgenic mice from SARS-CoV-2 infection (Liu et al., 2020).